TY  - JOUR
AU  - Guo, Feifei
AU  - Estevez-Vazquez, Olga
AU  - Benede-Ubieto, Raquel
AU  - Maya-Miles, Douglas
AU  - Zheng, Kang
AU  - Gallego-Duran, Rocio
AU  - Rojas, Angela
AU  - Ampuero, Javier
AU  - Romero-Gomez, Manuel
AU  - Philip, Kaye
AU  - Egbuniwe, Isioma U
AU  - Chen, Chaobo
AU  - Simon, Jorge
AU  - Delgado, Teresa C
AU  - Martinez-Chantar, Maria Luz
AU  - Sun, Jie
AU  - Reissing, Johanna
AU  - Bruns, Tony
AU  - Lamas-Paz, Arantza
AU  - Gomez-del-Moral, Manuel 
AU  - Woitok, Marius Maximilian
AU  - Vaquero, Javier
AU  - Regueiro, Jose R
AU  - Liedtke, Christian
AU  - Trautwein, Christian
AU  - Bañares, Rafael
AU  - Cubero, Francisco Javier
AU  - Nevzorova, Yulia A
PY  - 2021
DO  - 10.3390/cancers14010192
SN  - 2072-6694
UR  - http://hdl.handle.net/10668/20863
T2  - Cancers
AB  - Metabolic-associated fatty liver disease (MAFLD) has risen as one of the leading etiologies for hepatocellular carcinoma (HCC). Oncogenes have been suggested to be responsible for the high risk of MAFLD-related HCC. We analyzed the impact of the...
LA  - en
PB  - MDPI AG
KW  - c-myc
KW  - metabolic-associated fatty liver disease (MAFLD)
KW  - metformin
KW  - oncogene
KW  - tumorigenesis
KW  - Carcinoma, Hepatocellular
KW  - Reactive Oxygen Species
KW  - Metformin
KW  - Hyperlipidemias
KW  - Immunohistochemistry
KW  - Liver Neoplasms
KW  - Biopsy
KW  - Triglycerides
KW  - Diet, Western
TI  - A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy.
TY  - research article
VL  - 14
ER  -